
    
      This is a randomized, controlled, open-label superiority trial involving 50 individuals with
      OUD. Participants will be randomized into two arms: rapid micro-induction and standard
      induction (based on the American Society of Addiction Medicine Practice Guidelines and
      product monograph) of bup/nx.
    
  